BIOCANCER is an oncology-focused drug development service company which helps provide pharmaceutical, biotechnology, medical device and drug development companies with access to Brazil's large patient populations.
Our services include: patient and investigator recruitment; clinical trial planning; protocol design and review; database design; data entry and cross-checking; biostatistical analysis; and clinical trial reports.
From the discovery stage to late-phase clinical trials, BIOCANCER's wide range of integrated services is designed to help companies reduce their costs, minimize risks and accelerate the time to market while optimizing the overall quality of the drug development process.
BIOCANCER has the capability to assist its sponsors with every aspect of drug development:
designing, conducting, and managing Phase I-IV clinical trials;
managing and performing due diligence of emerging technologies.
The regulatory strategy we employ is always based on our client’s specific aims, whether they wish to out-license an innovative technology or to obtain full regulatory approval for a drug, biologic or medical device
